ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Nasopharyngeal Carcinoma · Treatment in China

How much does nasopharyngeal carcinoma treatment cost in China?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Nasopharyngeal Carcinoma Answer length: short, citable
Quick answer

As an illustrative planning range, IMRT with concurrent chemotherapy is commonly budgeted at ¥90,000–¥180,000 (roughly US$12,500–25,000). Induction chemotherapy, nimotuzumab, PD-1 immunotherapy, PET-CT and management of complications are additional. These are budgeting figures, not a quotation.

In detail

The earlier version of this site quoted ¥80,000–¥150,000 (US$11,000–21,000). Costs have changed with newer agents and longer survival, so obtain an itemised written estimate after your stage and EBV DNA results are reviewed, and confirm whether it includes imaging, laboratory monitoring and dental care.

What this means in practice: this answer is part of the “Treatment in China” section of the Nasopharyngeal Carcinoma topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about nasopharyngeal carcinoma

See all 15 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWhat does a full nasopharyngeal cancer treatment course in China involve? FAQ index →Browse all frequently asked questions

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.